Global Immunosuppressants Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Immunosuppressants Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Immunosuppressants Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 Selective Immunosuppressants
  • 1.2.3 Tumor Necrosis Factor a (TNF-a) Inhibitors
  • 1.2.4 Interleukin Inhibitors
  • 1.2.5 Calcineurin Inhibitors
  • 1.2.6 Other
• 1.3 Market by Application
  • 1.3.1 Global Immunosuppressants Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Immunosuppressants Revenue Estimates and Forecasts 2019-2030
• 2.2 Global Immunosuppressants Revenue by Region
  • 2.2.1 Global Immunosuppressants Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Immunosuppressants Revenue by Region (2019-2024)
  • 2.2.3 Global Immunosuppressants Revenue by Region (2025-2030)
  • 2.2.4 Global Immunosuppressants Revenue Market Share by Region (2019-2030)
• 2.3 Global Immunosuppressants Sales Estimates and Forecasts 2019-2030
• 2.4 Global Immunosuppressants Sales by Region
  • 2.4.1 Global Immunosuppressants Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Immunosuppressants Sales by Region (2019-2024)
  • 2.4.3 Global Immunosuppressants Sales by Region (2025-2030)
  • 2.4.4 Global Immunosuppressants Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Immunosuppressants Sales by Manufacturers
  • 3.1.1 Global Immunosuppressants Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Immunosuppressants Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Immunosuppressants in 2023
• 3.2 Global Immunosuppressants Revenue by Manufacturers
  • 3.2.1 Global Immunosuppressants Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Immunosuppressants Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by Immunosuppressants Revenue in 2023
• 3.3 Global Key Players of Immunosuppressants, Industry Ranking, 2021 VS 2022
• 3.4 Global Immunosuppressants Sales Price by Manufacturers (2019-2024)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Immunosuppressants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Immunosuppressants, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Immunosuppressants, Product Offered and Application
• 3.8 Global Key Manufacturers of Immunosuppressants, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Immunosuppressants Sales by Type
  • 4.1.1 Global Immunosuppressants Historical Sales by Type (2019-2024)
  • 4.1.2 Global Immunosuppressants Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Immunosuppressants Sales Market Share by Type (2019-2030)
• 4.2 Global Immunosuppressants Revenue by Type
  • 4.2.1 Global Immunosuppressants Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Immunosuppressants Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Immunosuppressants Revenue Market Share by Type (2019-2030)
• 4.3 Global Immunosuppressants Price by Type
  • 4.3.1 Global Immunosuppressants Price by Type (2019-2024)
  • 4.3.2 Global Immunosuppressants Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global Immunosuppressants Sales by Application
  • 5.1.1 Global Immunosuppressants Historical Sales by Application (2019-2024)
  • 5.1.2 Global Immunosuppressants Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Immunosuppressants Sales Market Share by Application (2019-2030)
• 5.2 Global Immunosuppressants Revenue by Application
  • 5.2.1 Global Immunosuppressants Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Immunosuppressants Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Immunosuppressants Revenue Market Share by Application (2019-2030)
• 5.3 Global Immunosuppressants Price by Application
  • 5.3.1 Global Immunosuppressants Price by Application (2019-2024)
  • 5.3.2 Global Immunosuppressants Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada Immunosuppressants Market Size by Type
  • 6.1.1 US & Canada Immunosuppressants Sales by Type (2019-2030)
  • 6.1.2 US & Canada Immunosuppressants Revenue by Type (2019-2030)
• 6.2 US & Canada Immunosuppressants Market Size by Application
  • 6.2.1 US & Canada Immunosuppressants Sales by Application (2019-2030)
  • 6.2.2 US & Canada Immunosuppressants Revenue by Application (2019-2030)
• 6.3 US & Canada Immunosuppressants Market Size by Country
  • 6.3.1 US & Canada Immunosuppressants Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada Immunosuppressants Revenue by Country (2019-2030)
  • 6.3.3 US & Canada Immunosuppressants Sales by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Immunosuppressants Market Size by Type
  • 7.1.1 Europe Immunosuppressants Sales by Type (2019-2030)
  • 7.1.2 Europe Immunosuppressants Revenue by Type (2019-2030)
• 7.2 Europe Immunosuppressants Market Size by Application
  • 7.2.1 Europe Immunosuppressants Sales by Application (2019-2030)
  • 7.2.2 Europe Immunosuppressants Revenue by Application (2019-2030)
• 7.3 Europe Immunosuppressants Market Size by Country
  • 7.3.1 Europe Immunosuppressants Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Immunosuppressants Revenue by Country (2019-2030)
  • 7.3.3 Europe Immunosuppressants Sales by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Immunosuppressants Market Size by Type
  • 8.1.1 China Immunosuppressants Sales by Type (2019-2030)
  • 8.1.2 China Immunosuppressants Revenue by Type (2019-2030)
• 8.2 China Immunosuppressants Market Size by Application
  • 8.2.1 China Immunosuppressants Sales by Application (2019-2030)
  • 8.2.2 China Immunosuppressants Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Immunosuppressants Market Size by Type
  • 9.1.1 Asia Immunosuppressants Sales by Type (2019-2030)
  • 9.1.2 Asia Immunosuppressants Revenue by Type (2019-2030)
• 9.2 Asia Immunosuppressants Market Size by Application
  • 9.2.1 Asia Immunosuppressants Sales by Application (2019-2030)
  • 9.2.2 Asia Immunosuppressants Revenue by Application (2019-2030)
• 9.3 Asia Immunosuppressants Market Size by Region
  • 9.3.1 Asia Immunosuppressants Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Immunosuppressants Revenue by Region (2019-2030)
  • 9.3.3 Asia Immunosuppressants Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Immunosuppressants Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Immunosuppressants Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Immunosuppressants Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Immunosuppressants Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Immunosuppressants Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Immunosuppressants Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Immunosuppressants Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Immunosuppressants Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Immunosuppressants Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Immunosuppressants Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 Lupin Pharmaceuticals, Inc.
  • 11.1.1 Lupin Pharmaceuticals, Inc. Company Information
  • 11.1.2 Lupin Pharmaceuticals, Inc. Overview
  • 11.1.3 Lupin Pharmaceuticals, Inc. Immunosuppressants Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 Lupin Pharmaceuticals, Inc. Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Lupin Pharmaceuticals, Inc. Recent Developments
• 11.2 Sanofi
  • 11.2.1 Sanofi Company Information
  • 11.2.2 Sanofi Overview
  • 11.2.3 Sanofi Immunosuppressants Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 Sanofi Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Sanofi Recent Developments
• 11.3 Pfizer
  • 11.3.1 Pfizer Company Information
  • 11.3.2 Pfizer Overview
  • 11.3.3 Pfizer Immunosuppressants Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 Pfizer Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Pfizer Recent Developments
• 11.4 Alexion Pharmaceuticals, Inc
  • 11.4.1 Alexion Pharmaceuticals, Inc Company Information
  • 11.4.2 Alexion Pharmaceuticals, Inc Overview
  • 11.4.3 Alexion Pharmaceuticals, Inc Immunosuppressants Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.4.4 Alexion Pharmaceuticals, Inc Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Alexion Pharmaceuticals, Inc Recent Developments
• 11.5 Manus Aktteva Biopharma LLP
  • 11.5.1 Manus Aktteva Biopharma LLP Company Information
  • 11.5.2 Manus Aktteva Biopharma LLP Overview
  • 11.5.3 Manus Aktteva Biopharma LLP Immunosuppressants Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.5.4 Manus Aktteva Biopharma LLP Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Manus Aktteva Biopharma LLP Recent Developments
• 11.6 Glenmark Pharmaceuticals US
  • 11.6.1 Glenmark Pharmaceuticals US Company Information
  • 11.6.2 Glenmark Pharmaceuticals US Overview
  • 11.6.3 Glenmark Pharmaceuticals US Immunosuppressants Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.6.4 Glenmark Pharmaceuticals US Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Glenmark Pharmaceuticals US Recent Developments
• 11.7 Teva
  • 11.7.1 Teva Company Information
  • 11.7.2 Teva Overview
  • 11.7.3 Teva Immunosuppressants Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.7.4 Teva Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Teva Recent Developments
• 11.8 Janssen Biotech, Inc.
  • 11.8.1 Janssen Biotech, Inc. Company Information
  • 11.8.2 Janssen Biotech, Inc. Overview
  • 11.8.3 Janssen Biotech, Inc. Immunosuppressants Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.8.4 Janssen Biotech, Inc. Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Janssen Biotech, Inc. Recent Developments
• 11.9 Centocor, Inc.
  • 11.9.1 Centocor, Inc. Company Information
  • 11.9.2 Centocor, Inc. Overview
  • 11.9.3 Centocor, Inc. Immunosuppressants Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.9.4 Centocor, Inc. Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Centocor, Inc. Recent Developments
• 11.10 Novartis
  • 11.10.1 Novartis Company Information
  • 11.10.2 Novartis Overview
  • 11.10.3 Novartis Immunosuppressants Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.10.4 Novartis Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Novartis Recent Developments
• 11.11 AbbVie Inc
  • 11.11.1 AbbVie Inc Company Information
  • 11.11.2 AbbVie Inc Overview
  • 11.11.3 AbbVie Inc Immunosuppressants Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.11.4 AbbVie Inc Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 AbbVie Inc Recent Developments
• 11.12 Rakshit
  • 11.12.1 Rakshit Company Information
  • 11.12.2 Rakshit Overview
  • 11.12.3 Rakshit Immunosuppressants Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.12.4 Rakshit Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Rakshit Recent Developments
• 11.13 Roche
  • 11.13.1 Roche Company Information
  • 11.13.2 Roche Overview
  • 11.13.3 Roche Immunosuppressants Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.13.4 Roche Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 Roche Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Immunosuppressants Industry Chain Analysis
• 12.2 Immunosuppressants Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Immunosuppressants Production Mode & Process
• 12.4 Immunosuppressants Sales and Marketing
  • 12.4.1 Immunosuppressants Sales Channels
  • 12.4.2 Immunosuppressants Distributors
• 12.5 Immunosuppressants Customers

13 Immunosuppressants Market Dynamics

• 13.1 Immunosuppressants Industry Trends
• 13.2 Immunosuppressants Market Drivers
• 13.3 Immunosuppressants Market Challenges
• 13.4 Immunosuppressants Market Restraints

14 Key Findings in the Global Immunosuppressants Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

Table 1. Global Immunosuppressants Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Selective Immunosuppressants

Table 3. Major Manufacturers of Tumor Necrosis Factor a (TNF-a) Inhibitors

Table 4. Major Manufacturers of Interleukin Inhibitors

Table 5. Major Manufacturers of Calcineurin Inhibitors

Table 6. Major Manufacturers of Other

Table 7. Global Immunosuppressants Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Immunosuppressants Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 9. Global Immunosuppressants Revenue by Region (2019-2024) & (US$ Million)

Table 10. Global Immunosuppressants Revenue by Region (2025-2030) & (US$ Million)

Table 11. Global Immunosuppressants Revenue Market Share by Region (2019-2024)

Table 12. Global Immunosuppressants Revenue Market Share by Region (2025-2030)

Table 13. Global Immunosuppressants Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Table 14. Global Immunosuppressants Sales by Region (2019-2024) & (K Units)

Table 15. Global Immunosuppressants Sales by Region (2025-2030) & (K Units)

Table 16. Global Immunosuppressants Sales Market Share by Region (2019-2024)

Table 17. Global Immunosuppressants Sales Market Share by Region (2025-2030)

Table 18. Global Immunosuppressants Sales by Manufacturers (2019-2024) & (K Units)

Table 19. Global Immunosuppressants Sales Share by Manufacturers (2019-2024)

Table 20. Global Immunosuppressants Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 21. Global Immunosuppressants Revenue Market Share by Manufacturers (2019-2024)

Table 22. Global Key Players of Immunosuppressants, Industry Ranking, 2021 VS 2022 VS 2023

Table 23. Immunosuppressants Price by Manufacturers (2019-2024) & (US$/Unit)

Table 24. Global Immunosuppressants Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 25. Global Immunosuppressants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunosuppressants as of 2023)

Table 26. Global Key Manufacturers of Immunosuppressants, Manufacturing Base Distribution and Headquarters

Table 27. Global Key Manufacturers of Immunosuppressants, Product Offered and Application

Table 28. Global Key Manufacturers of Immunosuppressants, Date of Enter into This Industry

Table 29. Mergers & Acquisitions, Expansion Plans

Table 30. Global Immunosuppressants Sales by Type (2019-2024) & (K Units)

Table 31. Global Immunosuppressants Sales by Type (2025-2030) & (K Units)

Table 32. Global Immunosuppressants Sales Share by Type (2019-2024)

Table 33. Global Immunosuppressants Sales Share by Type (2025-2030)

Table 34. Global Immunosuppressants Revenue by Type (2019-2024) & (US$ Million)

Table 35. Global Immunosuppressants Revenue by Type (2025-2030) & (US$ Million)

Table 36. Global Immunosuppressants Revenue Share by Type (2019-2024)

Table 37. Global Immunosuppressants Revenue Share by Type (2025-2030)

Table 38. Immunosuppressants Price by Type (2019-2024) & (US$/Unit)

Table 39. Global Immunosuppressants Price Forecast by Type (2025-2030) & (US$/Unit)

Table 40. Global Immunosuppressants Sales by Application (2019-2024) & (K Units)

Table 41. Global Immunosuppressants Sales by Application (2025-2030) & (K Units)

Table 42. Global Immunosuppressants Sales Share by Application (2019-2024)

Table 43. Global Immunosuppressants Sales Share by Application (2025-2030)

Table 44. Global Immunosuppressants Revenue by Application (2019-2024) & (US$ Million)

Table 45. Global Immunosuppressants Revenue by Application (2025-2030) & (US$ Million)

Table 46. Global Immunosuppressants Revenue Share by Application (2019-2024)

Table 47. Global Immunosuppressants Revenue Share by Application (2025-2030)

Table 48. Immunosuppressants Price by Application (2019-2024) & (US$/Unit)

Table 49. Global Immunosuppressants Price Forecast by Application (2025-2030) & (US$/Unit)

Table 50. US & Canada Immunosuppressants Sales by Type (2019-2024) & (K Units)

Table 51. US & Canada Immunosuppressants Sales by Type (2025-2030) & (K Units)

Table 52. US & Canada Immunosuppressants Revenue by Type (2019-2024) & (US$ Million)

Table 53. US & Canada Immunosuppressants Revenue by Type (2025-2030) & (US$ Million)

Table 54. US & Canada Immunosuppressants Sales by Application (2019-2024) & (K Units)

Table 55. US & Canada Immunosuppressants Sales by Application (2025-2030) & (K Units)

Table 56. US & Canada Immunosuppressants Revenue by Application (2019-2024) & (US$ Million)

Table 57. US & Canada Immunosuppressants Revenue by Application (2025-2030) & (US$ Million)

Table 58. US & Canada Immunosuppressants Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 59. US & Canada Immunosuppressants Revenue by Country (2019-2024) & (US$ Million)

Table 60. US & Canada Immunosuppressants Revenue by Country (2025-2030) & (US$ Million)

Table 61. US & Canada Immunosuppressants Sales by Country (2019-2024) & (K Units)

Table 62. US & Canada Immunosuppressants Sales by Country (2025-2030) & (K Units)

Table 63. Europe Immunosuppressants Sales by Type (2019-2024) & (K Units)

Table 64. Europe Immunosuppressants Sales by Type (2025-2030) & (K Units)

Table 65. Europe Immunosuppressants Revenue by Type (2019-2024) & (US$ Million)

Table 66. Europe Immunosuppressants Revenue by Type (2025-2030) & (US$ Million)

Table 67. Europe Immunosuppressants Sales by Application (2019-2024) & (K Units)

Table 68. Europe Immunosuppressants Sales by Application (2025-2030) & (K Units)

Table 69. Europe Immunosuppressants Revenue by Application (2019-2024) & (US$ Million)

Table 70. Europe Immunosuppressants Revenue by Application (2025-2030) & (US$ Million)

Table 71. Europe Immunosuppressants Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 72. Europe Immunosuppressants Revenue by Country (2019-2024) & (US$ Million)

Table 73. Europe Immunosuppressants Revenue by Country (2025-2030) & (US$ Million)

Table 74. Europe Immunosuppressants Sales by Country (2019-2024) & (K Units)

Table 75. Europe Immunosuppressants Sales by Country (2025-2030) & (K Units)

Table 76. China Immunosuppressants Sales by Type (2019-2024) & (K Units)

Table 77. China Immunosuppressants Sales by Type (2025-2030) & (K Units)

Table 78. China Immunosuppressants Revenue by Type (2019-2024) & (US$ Million)

Table 79. China Immunosuppressants Revenue by Type (2025-2030) & (US$ Million)

Table 80. China Immunosuppressants Sales by Application (2019-2024) & (K Units)

Table 81. China Immunosuppressants Sales by Application (2025-2030) & (K Units)

Table 82. China Immunosuppressants Revenue by Application (2019-2024) & (US$ Million)

Table 83. China Immunosuppressants Revenue by Application (2025-2030) & (US$ Million)

Table 84. Asia Immunosuppressants Sales by Type (2019-2024) & (K Units)

Table 85. Asia Immunosuppressants Sales by Type (2025-2030) & (K Units)

Table 86. Asia Immunosuppressants Revenue by Type (2019-2024) & (US$ Million)

Table 87. Asia Immunosuppressants Revenue by Type (2025-2030) & (US$ Million)

Table 88. Asia Immunosuppressants Sales by Application (2019-2024) & (K Units)

Table 89. Asia Immunosuppressants Sales by Application (2025-2030) & (K Units)

Table 90. Asia Immunosuppressants Revenue by Application (2019-2024) & (US$ Million)

Table 91. Asia Immunosuppressants Revenue by Application (2025-2030) & (US$ Million)

Table 92. Asia Immunosuppressants Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 93. Asia Immunosuppressants Revenue by Region (2019-2024) & (US$ Million)

Table 94. Asia Immunosuppressants Revenue by Region (2025-2030) & (US$ Million)

Table 95. Asia Immunosuppressants Sales by Region (2019-2024) & (K Units)

Table 96. Asia Immunosuppressants Sales by Region (2025-2030) & (K Units)

Table 97. Middle East, Africa and Latin America Immunosuppressants Sales by Type (2019-2024) & (K Units)

Table 98. Middle East, Africa and Latin America Immunosuppressants Sales by Type (2025-2030) & (K Units)

Table 99. Middle East, Africa and Latin America Immunosuppressants Revenue by Type (2019-2024) & (US$ Million)

Table 100. Middle East, Africa and Latin America Immunosuppressants Revenue by Type (2025-2030) & (US$ Million)

Table 101. Middle East, Africa and Latin America Immunosuppressants Sales by Application (2019-2024) & (K Units)

Table 102. Middle East, Africa and Latin America Immunosuppressants Sales by Application (2025-2030) & (K Units)

Table 103. Middle East, Africa and Latin America Immunosuppressants Revenue by Application (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Immunosuppressants Revenue by Application (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Immunosuppressants Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 106. Middle East, Africa and Latin America Immunosuppressants Revenue by Country (2019-2024) & (US$ Million)

Table 107. Middle East, Africa and Latin America Immunosuppressants Revenue by Country (2025-2030) & (US$ Million)

Table 108. Middle East, Africa and Latin America Immunosuppressants Sales by Country (2019-2024) & (K Units)

Table 109. Middle East, Africa and Latin America Immunosuppressants Sales by Country (2025-2030) & (K Units)

Table 110. Lupin Pharmaceuticals, Inc. Company Information

Table 111. Lupin Pharmaceuticals, Inc. Description and Major Businesses

Table 112. Lupin Pharmaceuticals, Inc. Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Lupin Pharmaceuticals, Inc. Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications

Table 114. Lupin Pharmaceuticals, Inc. Recent Developments

Table 115. Sanofi Company Information

Table 116. Sanofi Description and Major Businesses

Table 117. Sanofi Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Sanofi Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications

Table 119. Sanofi Recent Developments

Table 120. Pfizer Company Information

Table 121. Pfizer Description and Major Businesses

Table 122. Pfizer Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Pfizer Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications

Table 124. Pfizer Recent Developments

Table 125. Alexion Pharmaceuticals, Inc Company Information

Table 126. Alexion Pharmaceuticals, Inc Description and Major Businesses

Table 127. Alexion Pharmaceuticals, Inc Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Alexion Pharmaceuticals, Inc Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications

Table 129. Alexion Pharmaceuticals, Inc Recent Developments

Table 130. Manus Aktteva Biopharma LLP Company Information

Table 131. Manus Aktteva Biopharma LLP Description and Major Businesses

Table 132. Manus Aktteva Biopharma LLP Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Manus Aktteva Biopharma LLP Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications

Table 134. Manus Aktteva Biopharma LLP Recent Developments

Table 135. Glenmark Pharmaceuticals US Company Information

Table 136. Glenmark Pharmaceuticals US Description and Major Businesses

Table 137. Glenmark Pharmaceuticals US Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Glenmark Pharmaceuticals US Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications

Table 139. Glenmark Pharmaceuticals US Recent Developments

Table 140. Teva Company Information

Table 141. Teva Description and Major Businesses

Table 142. Teva Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 143. Teva Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications

Table 144. Teva Recent Developments

Table 145. Janssen Biotech, Inc. Company Information

Table 146. Janssen Biotech, Inc. Description and Major Businesses

Table 147. Janssen Biotech, Inc. Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 148. Janssen Biotech, Inc. Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications

Table 149. Janssen Biotech, Inc. Recent Developments

Table 150. Centocor, Inc. Company Information

Table 151. Centocor, Inc. Description and Major Businesses

Table 152. Centocor, Inc. Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 153. Centocor, Inc. Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications

Table 154. Centocor, Inc. Recent Developments

Table 155. Novartis Company Information

Table 156. Novartis Description and Major Businesses

Table 157. Novartis Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 158. Novartis Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications

Table 159. Novartis Recent Developments

Table 160. AbbVie Inc Company Information

Table 161. AbbVie Inc Description and Major Businesses

Table 162. AbbVie Inc Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 163. AbbVie Inc Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications

Table 164. AbbVie Inc Recent Developments

Table 165. Rakshit Company Information

Table 166. Rakshit Description and Major Businesses

Table 167. Rakshit Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 168. Rakshit Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications

Table 169. Rakshit Recent Developments

Table 170. Roche Company Information

Table 171. Roche Description and Major Businesses

Table 172. Roche Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 173. Roche Immunosuppressants Product Model Numbers, Pictures, Descriptions and Specifications

Table 174. Roche Recent Developments

Table 175. Key Raw Materials Lists

Table 176. Raw Materials Key Suppliers Lists

Table 177. Immunosuppressants Distributors List

Table 178. Immunosuppressants Customers List

Table 179. Immunosuppressants Market Trends

Table 180. Immunosuppressants Market Drivers

Table 181. Immunosuppressants Market Challenges

Table 182. Immunosuppressants Market Restraints

Table 183. Research Programs/Design for This Report

Table 184. Key Data Information from Secondary Sources

Table 185. Key Data Information from Primary Sources

List of Figures

Figure 1. Immunosuppressants Product Picture

Figure 2. Global Immunosuppressants Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Immunosuppressants Market Share by Type: 2023 & 2030

Figure 4. Selective Immunosuppressants Product Picture

Figure 5. Tumor Necrosis Factor a (TNF-a) Inhibitors Product Picture

Figure 6. Interleukin Inhibitors Product Picture

Figure 7. Calcineurin Inhibitors Product Picture

Figure 8. Other Product Picture

Figure 9. Global Immunosuppressants Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 10. Global Immunosuppressants Market Share by Application: 2023 & 2030

Figure 11. Hospital

Figure 12. Clinic

Figure 13. Other

Figure 14. Immunosuppressants Report Years Considered

Figure 15. Global Immunosuppressants Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Immunosuppressants Revenue (2019-2030) & (US$ Million)

Figure 17. Global Immunosuppressants Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 18. Global Immunosuppressants Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 19. Global Immunosuppressants Revenue Market Share by Region (2019-2030)

Figure 20. Global Immunosuppressants Sales (2019-2030) & (K Units)

Figure 21. Global Immunosuppressants Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Figure 22. Global Immunosuppressants Sales Market Share by Region (2019-2030)

Figure 23. US & Canada Immunosuppressants Sales YoY (2019-2030) & (K Units)

Figure 24. US & Canada Immunosuppressants Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Europe Immunosuppressants Sales YoY (2019-2030) & (K Units)

Figure 26. Europe Immunosuppressants Revenue YoY (2019-2030) & (US$ Million)

Figure 27. China Immunosuppressants Sales YoY (2019-2030) & (K Units)

Figure 28. China Immunosuppressants Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Asia (excluding China) Immunosuppressants Sales YoY (2019-2030) & (K Units)

Figure 30. Asia (excluding China) Immunosuppressants Revenue YoY (2019-2030) & (US$ Million)

Figure 31. Middle East, Africa and Latin America Immunosuppressants Sales YoY (2019-2030) & (K Units)

Figure 32. Middle East, Africa and Latin America Immunosuppressants Revenue YoY (2019-2030) & (US$ Million)

Figure 33. Global Immunosuppressants Sales Share by Manufacturers (2023)

Figure 34. The Immunosuppressants Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 35. Global Immunosuppressants Revenue Share by Manufacturers (2023)

Figure 36. The Top 5 and 10 Largest Manufacturers of Immunosuppressants in the World: Market Share by Immunosuppressants Revenue in 2023

Figure 37. Global Immunosuppressants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 38. Global Immunosuppressants Sales Market Share by Type (2019-2030)

Figure 39. Global Immunosuppressants Revenue Market Share by Type (2019-2030)

Figure 40. Global Immunosuppressants Sales Market Share by Application (2019-2030)

Figure 41. Global Immunosuppressants Revenue Market Share by Application (2019-2030)

Figure 42. US & Canada Immunosuppressants Sales Market Share by Type (2019-2030)

Figure 43. US & Canada Immunosuppressants Revenue Market Share by Type (2019-2030)

Figure 44. US & Canada Immunosuppressants Sales Market Share by Application (2019-2030)

Figure 45. US & Canada Immunosuppressants Revenue Market Share by Application (2019-2030)

Figure 46. US & Canada Immunosuppressants Revenue Share by Country (2019-2030)

Figure 47. US & Canada Immunosuppressants Sales Share by Country (2019-2030)

Figure 48. US Immunosuppressants Revenue (2019-2030) & (US$ Million)

Figure 49. Canada Immunosuppressants Revenue (2019-2030) & (US$ Million)

Figure 50. Europe Immunosuppressants Sales Market Share by Type (2019-2030)

Figure 51. Europe Immunosuppressants Revenue Market Share by Type (2019-2030)

Figure 52. Europe Immunosuppressants Sales Market Share by Application (2019-2030)

Figure 53. Europe Immunosuppressants Revenue Market Share by Application (2019-2030)

Figure 54. Europe Immunosuppressants Revenue Share by Country (2019-2030)

Figure 55. Europe Immunosuppressants Sales Share by Country (2019-2030)

Figure 56. Germany Immunosuppressants Revenue (2019-2030) & (US$ Million)

Figure 57. France Immunosuppressants Revenue (2019-2030) & (US$ Million)

Figure 58. U.K. Immunosuppressants Revenue (2019-2030) & (US$ Million)

Figure 59. Italy Immunosuppressants Revenue (2019-2030) & (US$ Million)

Figure 60. Russia Immunosuppressants Revenue (2019-2030) & (US$ Million)

Figure 61. China Immunosuppressants Sales Market Share by Type (2019-2030)

Figure 62. China Immunosuppressants Revenue Market Share by Type (2019-2030)

Figure 63. China Immunosuppressants Sales Market Share by Application (2019-2030)

Figure 64. China Immunosuppressants Revenue Market Share by Application (2019-2030)

Figure 65. Asia Immunosuppressants Sales Market Share by Type (2019-2030)

Figure 66. Asia Immunosuppressants Revenue Market Share by Type (2019-2030)

Figure 67. Asia Immunosuppressants Sales Market Share by Application (2019-2030)

Figure 68. Asia Immunosuppressants Revenue Market Share by Application (2019-2030)

Figure 69. Asia Immunosuppressants Revenue Share by Region (2019-2030)

Figure 70. Asia Immunosuppressants Sales Share by Region (2019-2030)

Figure 71. Japan Immunosuppressants Revenue (2019-2030) & (US$ Million)

Figure 72. South Korea Immunosuppressants Revenue (2019-2030) & (US$ Million)

Figure 73. China Taiwan Immunosuppressants Revenue (2019-2030) & (US$ Million)

Figure 74. Southeast Asia Immunosuppressants Revenue (2019-2030) & (US$ Million)

Figure 75. India Immunosuppressants Revenue (2019-2030) & (US$ Million)

Figure 76. Australia Immunosuppressants Revenue (2019-2030) & (US$ Million)

Figure 77. Middle East, Africa and Latin America Immunosuppressants Sales Market Share by Type (2019-2030)

Figure 78. Middle East, Africa and Latin America Immunosuppressants Revenue Market Share by Type (2019-2030)

Figure 79. Middle East, Africa and Latin America Immunosuppressants Sales Market Share by Application (2019-2030)

Figure 80. Middle East, Africa and Latin America Immunosuppressants Revenue Market Share by Application (2019-2030)

Figure 81. Middle East, Africa and Latin America Immunosuppressants Revenue Share by Country (2019-2030)

Figure 82. Middle East, Africa and Latin America Immunosuppressants Sales Share by Country (2019-2030)

Figure 83. Brazil Immunosuppressants Revenue (2019-2030) & (US$ Million)

Figure 84. Mexico Immunosuppressants Revenue (2019-2030) & (US$ Million)

Figure 85. Turkey Immunosuppressants Revenue (2019-2030) & (US$ Million)

Figure 86. Israel Immunosuppressants Revenue (2019-2030) & (US$ Million)

Figure 87. GCC Countries Immunosuppressants Revenue (2019-2030) & (US$ Million)

Figure 88. Immunosuppressants Value Chain

Figure 89. Immunosuppressants Production Process

Figure 90. Channels of Distribution (Direct Vs Distribution)

Figure 91. Bottom-up and Top-down Approaches for This Report

Figure 92. Data Triangulation

Figure 93. Key Executives Interviewed